Before joining the group, Clarke has enjoyed a 35 year career at GSK, culminating in his appointment at president of consumer healthcare – a position he recently abdicated.
At Futura, he replaces William Potter, who will step down from the board in February. He will remain at Futura as chief scientific officer.
Of his new role, Clarke said: “I am particularly impressed by the level of innovation at Futura, by the commercial potential of its late stage products and by the breadth of its product pipeline. I look forward to assisting the company in achieving its true potential.”